Topic

Created by jon on 4/26/2007

Orexigen Therapeutics, Inc. ^en

mid: /m/03p3q2f notable type: /organization/organization notable for: /organization/organization on the web: croctail.corpwatch.org

OREXIGEN™ Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system disorders, with an initial focus on obesity. OREXIGEN’s lead combination product candidates targeted for obesity are Contrave™, which is in a Phase III clinical trial, and Empatic™ (formerly Excalia™), which is in a Phase IIb clinical trial. [ - ]

Types:

Add type

Metaweb System Types

Object

Common

Topic

Freebase

Object profile

Organization

Organization

alust's types

Processed with Review Queue

Object is not asserted on this topic.

ID /type/object/id

GUID /type/object/guid

#9202a8c04000641f800000000751d84d

Type /type/object/type

Name /type/object/name

- - Edit
  - Delete
Orexigen Therapeutics, Inc.

Key /type/object/key

Timestamp /type/object/timestamp

Thursday, April 26, 2007 12:06 AM

Permission /type/object/permission

/boot/all_permission

Creator /type/object/creator

Attribution /type/object/attribution

Search /type/object/search

Machine ID /type/object/mid

/m/03p3q2f

Also known as /common/topic/alias

- - Edit
  - Delete
Orexigen
- - Edit
  - Delete
Orexigen Therapeutics Inc
- - Edit
  - Delete
Orexigen.com

Description /common/topic/description

- - Edit
  - Delete
OREXIGEN™ Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system disorders, with an initial focus on obesity. OREXIGEN’s lead combination product candidates targeted for obesity are Contrave™, which is in a Phase III clinical trial, and Empatic™ (formerly Excalia™), which is in a Phase IIb clinical trial.

Image /common/topic/image

Official website /common/topic/official_website

- - Edit
  - Delete
http://www.orexigen.com/

Topic equivalent webpage /common/topic/topic_equivalent_webpage

Social media presence /common/topic/social_media_presence

Topical webpage /common/topic/topical_webpage

- - Edit
  - Delete
http://www.freshnews.com/news/tech-people-move/article_30338.html?Kleiner%20Perkins%20Caufield

Subjects /common/topic/subjects

Subject of /common/topic/subject_of

Web Link(s) (deprecated) /common/topic/webpage

-

Properties /common/topic/properties

Article /common/topic/article

<span class="sub_text"><h1></h1> <span class="page_text"><p> OREXIGEN™ Therapeutics, Inc. is...

Weblink /common/topic/weblink

Notable for /common/topic/notable_for

Organization

Notable types /common/topic/notable_types

Employees and other personnel /business/employer/employees

Person	Title	From	To
Edit Delete Edit localized... View CVT Gary D. Tollefson	President and CEO	2005 May	-
Edit Delete Edit localized... View CVT Anthony A. McKinney	Chief Operating Officer	2005 January	-
Edit Delete Edit localized... View CVT Heather D. Turner	Vice President and General Counsel	2007 July	-
Edit Delete Edit localized... View CVT Graham Cooper	Chief Financial Officer, Secretary and Treasurer	2006 May	-
Edit Delete Edit localized... View CVT Michael A. Cowley	Chief Scientific Officer	2006 November	-
Edit Delete Edit localized... View CVT Eduardo Dunayevich	-	2006 August	-
Edit Delete Edit localized... View CVT Ronald P. Landbloom	Vice President of Medical and Regulatory Affairs	2006 September	-
Edit Delete Edit localized... View CVT Franklin P. Bymaster	Vice President of Neuroscience	2006 September	-
Edit Delete Edit localized... View CVT James C. Lancaster Jr.	Vice President, Commercial Operations	2006 August	-
Edit Delete Edit localized... View CVT Franklin P. Bymaster	Vice President	-	-
18 values total »

Number of employees /business/employer/number_of_employees

number	date	Source
-

Venture Investors /venture_capital/venture_funded_company/venture_investors

Investor	Investment Round	Date	Currency	Amount
Edit Delete Edit localized... View CVT BA Venture Partners	-	-	-	-
Edit Delete Edit localized... View CVT Morgenthaler Ventures	-	-	-	-
Edit Delete Edit localized... View CVT Montreux Equity Partners	-	-	-	-
Edit Delete Edit localized... View CVT Sofinnova Ventures	-	-	-	-
Edit Delete Edit localized... View CVT Domain Associates	-	-	-	-
Edit Delete Edit localized... View CVT Scale Venture Partners	-	-	-	-
Edit Delete Edit localized... View CVT Kleiner, Perkins, Caufield and Byers	-	-	-	-

Total Venture Investment Raised /venture_capital/venture_funded_company/total_venture_investment_raised

Currency	Amount	Valid Date	Source
-

Revenue /business/business_operation/revenue

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	90,000.00	12/31/2008	-

Operating Income /business/business_operation/operating_income

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	-94,820,000.00	12/31/2008	-

Net profit /business/business_operation/net_profit

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	-93,240,000.00	12/31/2008	-

Total annual expenses /business/business_operation/total_annual_expenses

Currency	Amount	Valid Date	Source
-

Cash /business/business_operation/cash

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	45,450,000.00	12/31/2008	-

Current Assets /business/business_operation/current_assets

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	87,350,000.00	12/31/2008	-

Total Assets /business/business_operation/assets

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	91,910,000.00	12/31/2008	-

Current Liabilities /business/business_operation/current_liabilities

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	26,490,000.00	12/31/2008	-

Total Liabilities /business/business_operation/liabilities

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	38,110,000.00	12/31/2008	-

Retained Earnings /business/business_operation/retained_earnings

Currency	Amount	Valid Date	Source
Edit Delete Edit localized... View CVT United States dollar	-200,180,000.00	12/31/2008	-

Competitive space /business/business_operation/competitive_space

Space	Brand	Portion
Edit Delete Edit localized... View CVT Anti-obesity medication	Bupropion/naltrexone	-

Major customer /business/business_operation/major_customer

Industry /business/business_operation/industry

Market capitalization /business/business_operation/market_capitalization

Currency	Amount	Valid Date	Source
-

Issue /business/issuer/issue

OREXIGEN THERAPEUTICS INC Common Stock

Object profile is not asserted on this topic. Assert type now.

Object generation time /freebase/object_profile/object_generation_time

- - Edit
  - Delete
Thursday, May 23, 2013 9:21 AM

Link count /freebase/object_profile/link_count

Geographic scope /organization/organization/geographic_scope

Sectors /organization/organization/sectors

Headquarters /organization/organization/headquarters

Street Address	City/Town	State/Province/Region	Postal Code
Edit Delete View CVT 12481 High Bluff Drive	San Diego	California	92130
Edit Delete View CVT 3344 N. TORREY PINES CT.	La Jolla	California	92037
Edit Delete View CVT 12481 HIGH BLUFF DRIVE, SUITE 160	San Diego	California	92130

Date founded /organization/organization/date_founded

Founders /organization/organization/founders

Board members /organization/organization/board_members

Person	Title	Role	From	To
Edit Delete Edit localized... View CVT Joseph S. Lacob	-	-	2004 January	-
Edit Delete Edit localized... View CVT Eckard Weber	Chair	-	-	-
Edit Delete Edit localized... View CVT Gary D. Tollefson	-	-	2005 May	-
Edit Delete Edit localized... View CVT Daniel K. Turner III	-	-	2005 April	-
Edit Delete Edit localized... View CVT Michael F. Powell	-	-	2004 January	-
Edit Delete Edit localized... View CVT Brian H. Dovey	-	-	2004 January	-
Edit Delete Edit localized... View CVT Louis C. Bock	-	-	2005 April	-
Edit Delete Edit localized... View CVT Michael Powell	-	-	-	-
Edit Delete Edit localized... View CVT Daniel K Turner III	-	-	-	-
Edit Delete Edit localized... View CVT Brian H. Dovey	Director	-	-	-

Committees /organization/organization/committees

Organization type /organization/organization/organization_type

Involved in merger /organization/organization/involved_in_merger

Organizations merging	Date	Became organization
-

Product of merger /organization/organization/product_of_merger

Organizations merging	Date
-

Spun off from /organization/organization/spun_off_from

Parent organization	Date
-

Spin offs /organization/organization/spin_offs

Child organization	Date
-

Parent /organization/organization/parent

Parent	From	To
-

Child /organization/organization/child

Child	From	To
-

Legal structure /organization/organization/legal_structure

Place founded /organization/organization/place_founded

Slogan /organization/organization/slogan

Previous names /organization/organization/previous_names

Previous name	Start date	End date
-

Organization locations /organization/organization/locations

Advisors /organization/organization/advisors

Acquired by /organization/organization/acquired_by

Acquiring organization	Date	Divisions formed
-

Organizations acquired /organization/organization/companies_acquired

Organization acquired	Date	Divisions formed
-

Leadership /organization/organization/leadership

Person	Role	Title	From	To
-

Partnerships /organization/organization/partnerships

Email /organization/organization/email

Email address	Category
-

Phone number /organization/organization/phone_number

Country Code	Number	Category	Service location	Note
-

Internal Question ID /user/alust/default_domain/processed_with_review_queue/internal_question_id

Escalation Question ID /user/alust/default_domain/processed_with_review_queue/escalation_question_id

Question ID /user/alust/default_domain/processed_with_review_queue/question_id

- - Edit
  - Delete
/rabj/store/questions/question_d25cbbdc6e94bc47

Comments

Hide

Orexigen Therapeutics, Inc. ^en

Add type

Metaweb System Types

Common

Business

Freebase

Organization

alust's types

Freebase Commons Metaweb System Types /type

Object /type/object

Freebase Commons Common /common

Topic /common/topic x

Freebase Commons Business /business

Employer /business/employer x

Venture Funded Company /venture_capital/venture_funded_company x

Business Operation /business/business_operation x

Issuer /business/issuer x

Freebase Commons Freebase /freebase

Object profile /freebase/object_profile

Freebase Commons Organization /organization

Organization /organization/organization x

User Domain alust's types /user/alust/default_domain

Processed with Review Queue /user/alust/default_domain/processed_with_review_queue x

Comments

Orexigen Therapeutics, Inc. en

Freebase Commons Metaweb System Types /type

Freebase Commons Common /common

Freebase Commons Business /business

Freebase Commons Freebase /freebase

Freebase Commons Organization /organization

User Domain alust's types /user/alust/default_domain

Keyboard Shortcuts

Navigation

Editing

Comments

Wait!

Wait!

Orexigen Therapeutics, Inc. ^en